Eli Lilly Defeats Cymbalta Risk Claims In Bellwether Trial
A California federal jury Friday rejected claims by a woman who alleged Eli Lilly & Co. concealed the withdrawal risks of its antidepressant Cymbalta, finding the drugmaker did not mislabel the...To view the full article, register now.
Already a subscriber? Click here to view full article